Publications2023-08-23T10:08:45-04:00

Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients

Izhar S. Batth, Long Dao, Arun Satelli, Abhisek Mitra, Sofia Yi, Hyangsoon Noh, Heming Li, Zachary, Brownlee, Shouhao Zhou, Jeffrey Bond,  Jing Wang,  Jonathan Gill, Giselle S. Sholler, Shulin Li, Cell[...]

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma

Elizabeth C. Lewis, Jacqueline M. Kraveka, William Ferguson, Don Eslin, Valerie I. Brown, Genevieve Bergendahl, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Peter Zage, Jawhar Rawwas,[...]

A collaborative pediatric cancer precision medicine model leveraging shared genomic, clinical, and research data from high-risk solid tumor patients across 45 clinical sites

Giselle L. Saulnier Sholler, Jacqueline M. Kraveka, William Ferguson, Genevieve Bergendahl, William P. D. Hendricks, Abhinav Nagulapally, Sara A. Byron, James Lowey, William Burleson, Elizabeth VanSickle, Muhammed Murtaza, Matija Snuderl,[...]

Abstract|

Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses

Shukla GS, Sun YJ, Pero SC, Sholler GS, Krag DN. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.  J Immunol[...]

Peds-PLAN, pediatric precision laboratory advanced neuroblastoma therapy: Molecular guided therapy for high risk neuroblastoma at diagnosis

Jacqeline Kraveka, Valerie Brown, William Ferguson, Genevieve Bergendahl, William Roberts, Jessica Foley, Deanna Mitchell, Javier Oesterheld, Michael Isakoff, Kathleen Neville, Randal Wada, Jawhar Rawwas, Gina Hanna, Abhinav Beeravally Nagulapally, Jeffrey[...]

Abstract|

Peds-PLAN, pediatric precision laboratory advanced neuroblastoma therapy: Molecular guided therapy for high risk neuroblastoma at diagnosis

Jacqeline Kraveka, Valerie Brown, William Ferguson, Genevieve Bergendahl, William Roberts, Jessica Foley, Deanna Mitchell, Javier Oesterheld, Michael Isakoff, Kathleen Neville, Randal Wada, Jawhar Rawwas, Gina Hanna, Abhinav Beeravally Nagulapally, Jeffrey[...]

Abstract|

The MDM2 inhibitor CGM097 synergizes with the BET inhibitor OTX015 to induce cell death in neuroblastoma cells

Tyler Maser, Joseph Zagorski, Austin Goodyke, Elizabeth VanSickle, Jeffrey Bond, Giselle Sholler. The MDM2 inhibitor CGM097 synergizes with the BET inhibitor OTX015 to induce cell death in neuroblastoma cells, American Association for[...]

Abstract|

Genomic and high-throughput pharmacologic correlative analysis of 10 diffuse intrinsic pontine glioma

Elizabeth VanSickle, Abhinav Nagulapally, Delvano Capobianco, Jeff Bond, Rick Neubig, Tom Dexheimer, Giselle Sholler. Genomic and high-throughput pharmacologic correlative analysis of 10 diffuse intrinsic pontine glioma, 2nd Pediatric Precision Oncology Conference 2018, Scottsdale,[...]

Abstract|
Go to Top